We are live on ! Find out more
NDRM

NeuroDerm Ltd. Ordinary Shares
NDRM

Delisted

NDRM was delisted on the 17th of October, 2017.

Back to rankings

5 hedge funds and large institutions have $1.3M invested in NeuroDerm Ltd. Ordinary Shares in 2017 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 76 closing their positions.

New
Increased
Maintained
Reduced
Closed

94% less funds holding

Funds holding: 81 → 5 (-76)

99% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 76

100% less capital invested

Capital invested by funds: $501M → $1.3M (-$499M)

100% less funds holding in top 10

Funds holding in top 10: 3 → 0 (-3)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
5
Holders Change
-76
Holders Change %
-93.83%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
76
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
FWM
Focused Wealth Management
New York
+$1.25K

Top Sellers

Rank Fund Capital Flow
1
AA
AQR Arbitrage
Connecticut
-$53.3M
2
SAM
Sandell Asset Management
New York
-$43.9M
3
OP
Omni Partners
United Kingdom
-$43.4M
4
JP Morgan Chase
JP Morgan Chase
New York
-$28.8M
5
OAM
Oxford Asset Management
United Kingdom
-$22.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
SG Americas Securities
51
SG Americas Securities
New York
– -$1.34M -34,367 Closed
DCM
52
Dupont Capital Management
Delaware
– -$1.32M -33,900 Closed
SEC
53
Seven Eight Capital
New York
– -$1.12M -28,700 Closed
Swiss National Bank
54
Swiss National Bank
Switzerland
– -$1.1M -28,300 Closed
Ameriprise
55
Ameriprise
Minnesota
– -$1.03M -26,614 Closed
AA
56
ALPS Advisors
Colorado
– -$1.01M -25,936 Closed
PP
57
Paloma Partners
Connecticut
– -$984K -25,300 Closed
CS
58
Credit Suisse
Switzerland
– -$967K -24,860 Closed
Barclays
59
Barclays
United Kingdom
– -$912K -23,471 Closed
I
60
INVST
Indiana
– -$888K -22,833 Closed
PAM
61
Panagora Asset Management
Massachusetts
– -$816K -20,986 Closed
CL
62
CSS LLC
Illinois
– -$797K -20,496 Closed
DAM
63
DLD Asset Management
New York
– -$739K -19,000 Closed
Geode Capital Management
64
Geode Capital Management
Massachusetts
– -$693K -17,827 Closed
CSS
65
Cubist Systematic Strategies
Connecticut
– -$650K -16,697 Closed
Millennium Management
66
Millennium Management
New York
– -$584K -15,000 Closed
HCMT
67
Highland Capital Management (Texas)
Texas
– -$533K -13,700 Closed
PPA
68
Parametric Portfolio Associates
Washington
– -$467K -11,999 Closed
TCIM
69
TIAA CREF Investment Management
New York
– -$367K -9,437 Closed
OC
70
Oppenheimer & Co
New York
– -$337K -8,655 Closed
Simplex Trading
71
Simplex Trading
Illinois
– -$308K -7,928 Closed
EMG
72
ETF Managers Group
New Jersey
– -$291K -7,483 Closed
VanEck Associates
73
VanEck Associates
New York
– -$192K -4,943 Closed
QT
74
Quantbot Technologies
New York
– -$62K -1,600 Closed
Royal Bank of Canada
75
Royal Bank of Canada
Ontario, Canada
– -$39K -996 Closed
1 2
3
4

NDRM Hedge Fund Activity: Q4 2017 in Review

5 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in NeuroDerm Ltd. Ordinary Shares (NDRM) for Q4 2017, worth a combined $1.3M — down 100% from $501M a quarter earlier.

Sellers outnumbered buyers: 76 funds closed out of NDRM and 1 opened new positions — a net loss of 75 holders — while 1 trimmed existing stakes and 0 added.

The largest buyer was Focused Wealth Management, opening a new position worth an estimated $1.25K. The largest seller was AQR Arbitrage, exiting entirely with an estimated $53.3M sold.

  • 5 institutional investors held NeuroDerm Ltd. Ordinary Shares (NDRM) as of Q4 2017, down from 81 in Q3 2017.
  • Funds reported $1.3M of NeuroDerm Ltd. Ordinary Shares stock for Q4 2017, down 100% quarter-over-quarter.
  • 1 fund opened new NeuroDerm Ltd. Ordinary Shares positions in Q4 2017 and 76 closed out, a net change of -75 holders.
  • The largest NeuroDerm Ltd. Ordinary Shares buyer in Q4 2017 was Focused Wealth Management, an estimated $1.25K added.
  • The largest NeuroDerm Ltd. Ordinary Shares seller in Q4 2017 was AQR Arbitrage, an estimated $53.3M sold.

Based on aggregated 13F filings for Q4 2017.